A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial

Neuroprotective agents have the potential to improve the outcomes of revascularisation therapies in acute ischemic stroke patients (AIS) and in those unable to receive revascularisation. Afamelanotide, a synth...

Source: BMC Neurology - July 26, 2023 Category: Neurology Authors: Vimal Stanislaus, Anthony Kam, Lily Murphy, Philippe Wolgen, Gill Walker, Pilar Bilbao and Geoffrey C Cloud Tags: Research Source Type: research